Updated:
Cryoport
Founded by a team of physicians dedicated to life sciences logistics, Cryoport has grown from a shipping provider into a comprehensive supply chain...
Cryoport
Founded by a team of physicians dedicated to life sciences logistics, Cryoport has grown from a shipping provider into a comprehensive supply chain platform. The firm's integrated capabilities now span cryopreservation, biostorage, transportation, and consulting services, structuring an end-to-end chain of compliance that serves biopharmaceutical developers from preclinical research through global commercialization. Cryoport's strategy centers on owning the temperature-controlled logistics layer for complex biologics and advanced therapies. The platform is built around patented, ISO 21973-compliant shippers that are requalified on every shipment to maintain consistent cryogenic, ultra-cold, refrigerated, and controlled room temperature conditions. Its service footprint covers cell therapy, gene therapy, biologics, animal health, and reproductive medicine, with 650+ clinical trials supported. The firm operates as a standalone vendor, positioning its IntegriCell cryopreservation service to standardize leukapheresis starting material — a direct push into upstream supply chain quality control that differentiates it from generic logistics carriers. The firm manages its operations from its Brentwood, Tennessee headquarters, with 24/7/365 customer support and a global reach that has delivered successful shipments into markets such as Japan and Israel. Cryoport combined its logistics infrastructure with BioServices and biostorage capabilities, creating a multi-temperature storage and distribution network that now supports commercial advanced therapies alongside clinical trial material management. Its proprietary Chain of Compliance tracking provides the traceability required by cell and gene therapy developers facing stringent regulatory oversight. Structurally, Cryoport is distinct because it serves as the sole provider that bundles cryogenic shipping, biostorage, and cryopreservation standardization under a single quality system — a posture that turns logistics from a cost center into a risk-mitigation subscription for therapy developers. Its Veri-Clean process and mandatory shipment-level requalification create an operational moat in a sector where batch failure can destroy clinical trial outcomes.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Brentwood
Corporate office
Brentwood, TN, United States
Sector focus
Frequently asked questions
How does Cryoport's supply chain platform differ from standard cold-chain logistics providers?
Cryoport bundles patented, ISO 21973-compliant shippers with mandatory requalification on every shipment — a discipline standard logistics carriers do not apply. Its Chain of Compliance tracking creates an unbroken custody record for sensitive biologics, and the IntegriCell cryopreservation service standardizes leukapheresis starting material, which pushes the firm's role upstream into therapy quality control.
Which therapy modalities and development phases does Cryoport support?
Cryoport's platform actively covers cell therapy, gene therapy, biologics, animal health, and reproductive medicine. Its stated scope spans clinical trials through commercial distribution, with more than 650 clinical trials supported and integrated BioServices supplying storage and logistics for both trial and commercial material.
Is Cryoport a direct investor in life sciences companies, or purely a service provider?
From its own disclosures, Cryoport operates solely as a temperature-controlled supply chain management and services platform; there is no public indication that it deploys capital into life sciences companies as an investor. The firm's business model is built on logistics, biostorage, and consulting revenue from biopharmaceutical clients.
How does Cryoport maintain quality across its global network?
The firm relies on its proprietary Veri-Clean process, mandatory shipment-level requalification of all shippers, and an auditable Chain of Compliance log. ISO 21973 certification governs the shipping systems, and a 24/7/365 customer support operation — reachable through a Tennessee-based command center — coordinates global movements in cryogenic, ultra-cold, refrigerated, and controlled room temperature conditions.
Does Cryoport offer biostorage and cryopreservation in addition to transportation?
Yes. Through its BioServices & Biostorage arm, Cryoport manages biomaterials across the supply chain, and its IntegriCell cryopreservation service standardizes protocols for leukapheresis starting material. These services sit alongside transportation and consulting, making the firm a bundled temperature-controlled supply chain provider rather than a transportation-only vendor.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: